Clinical Trials Search Results

1.

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 85
Trial IDs: J07122, NCI-2010-02020, JHOC-J07122, JHOC-NA_00010227, NCT00670046

2.

Valproic Acid and Radiation Therapy Followed by Maintenance Valproic Acid and Bevacizumab in Treating Young Patients With Newly Diagnosed High-Grade Gliomas

Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 to 21
Trial IDs: H-24549, NCI-2012-00618, NCT00879437

3.

Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients with Recurrent or Progressive High-Grade Glioma

Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MCC-14816, NCI-2013-00705, CTC-11-011, MCC-14816 (CTC-11-011), NCT01817751

4.

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13P.377, NCI-2014-00338, 2013-047, NCT02068586

5.

Bevacizumab and Temsirolimus Alone or in Combination with Valproic Acid or Cetuximab in Treating Patients with Advanced or Metastatic Malignancy or Other Benign Disease

Status: Active
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2012-0061, NCI-2012-00347, NCT01552434

6.

Folate Receptor in Diagnosing Ovarian Cancer using Serum Samples from Patients with Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer

Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 18 and over
Trial IDs: 2015-024, NCI-2015-01039, 1504013983, NCT02520115

7.

Stereotactic Radiosurgery, Nivolumab, and Valproic Acid in Treating Patients with Recurrent Glioblastoma

Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CA209-378, NCI-2016-01238, 18574, NCT02648633

Clinical Trials Search Results

Results 1-7 of 7 for your search: